Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
19:44
Estonian Prime Minister Kristen Michal rejects appeals from Washington and maintains his harsh criticism of Vladimir Putin
19:36
Admiral Tony Radakin argues that Ukraine will win the war thanks to rapid adaptation and drone production
19:27
A Romanian worker died after falling from a ladder at a construction site in Belgium
19:22
Over 600,000 employees in Belgium will receive a 4.65% salary increase from January 2027 through automatic indexation
19:18
Italy’s government proposes pension funds for children, longer parental leave, and vouchers for self-employed workers
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
